Klea Holding SA (FRA:7V91)

Market Cap	45.43M -31.2%
Revenue (ttm)	22.17M +28.4%
Net Income	2.28M +62.3%
EPS	0.01 +84.6%
Shares Out	n/a
PE Ratio	19.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1358
Previous Close	0.1358
Day's Range	0.1358 - 0.1358
52-Week Range	0.1358 - 0.3000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 18, 2026

About Klea Holding

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 200...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2007
• Employees: 128
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7V91

Financial Performance

In 2025, Klea Holding's revenue was 22.17 million, an increase of 28.42% compared to the previous year's 17.26 million. Earnings were 2.28 million, an increase of 62.35%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 8, 2026

Data Sources Report a data error